Case Study

Automated ultrasound for non-invasive in vivo evaluation of liver disease progression in mice

vega-liver-image512

Being able to characterize and monitor the extent of fibrosis, steatosis, and inflammation in the liver non-invasively is valuable to clinicians and researchers to comprehensively stage disease progression and evaluate therapeutic response.

Read this review to learn how researchers used the Vega® automated, hands-free, high-throughput ultrasound system as a turnkey solution to evaluate, monitor, and quantify liver disease progression in murine models.

Case studies include:

  • Evaluation of NAFLD using a mouse western diet mouse model
  • Disease progression in a chemically induced mouse fibrosis model
  • Monitoring treatment response in Mdr2 knockout mice
  • Multimodal imaging of NAFLD/NASH progression in mouse model

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Automated ultrasound for non-invasive in vivo evaluation of liver disease progression in mice

Download Case Study